Literature DB >> 20331384

Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population.

Priya Sakthivel1, Fredrik Wermeling, Anders Elmgren, Johannes Hulthe, Maria Kakoulidou, Ann Kari Lefvert, Lars Lind.   

Abstract

OBJECTIVE: Measurement of inflammatory mediators is an important tool to assess inflammation. We have, therefore, conducted a survey within the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study to evaluate the inter-relationship between soluble CTLA-4 (sCTLA-4) and other inflammatory markers.
MATERIALS AND METHODS: This is a population-based study, designed to quantify the circulating serum levels of sCTLA-4 and other inflammatory markers such as CRP and pro-inflammatory cytokines and chemokines by in-house ELISA, Immuno-turbidimetry and multiplex ELISA, respectively. A total of 1016 Swedish Caucasians aged 70 years old were recruited. The statistical analysis was performed by ANOVA.
RESULTS: The levels of sCTLA-4 were directly related to the levels of pro-inflammatory cytokines such as IL-6, IL-1alpha, IL-1beta, TNF-alpha, IFN-gamma and chemokines such as IL-8. However, the levels of sCTLA-4 were inversely related to the levels of MCP-1. Also, we could not demonstrate any relation between the levels of sCTLA-4 and CRP or soluble adhesion molecules.
CONCLUSIONS: Circulating sCTLA-4 could be used as a biomarker for inflammation, potentially reflecting dysregulated T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20331384     DOI: 10.3109/00365511003695608

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

1.  Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome.

Authors:  Duygu Ozkorucu; Nuran Cetin; Nadide Melike Sav; Bilal Yildiz
Journal:  Int Urol Nephrol       Date:  2016-02-27       Impact factor: 2.370

2.  CTLA-4 as a genetic determinant in autoimmune Addison's disease.

Authors:  A S B Wolff; A L Mitchell; H J Cordell; A Short; B Skinningsrud; W Ollier; K Badenhoop; G Meyer; A Falorni; O Kampe; D Undlien; S H S Pearce; E S Husebye
Journal:  Genes Immun       Date:  2015-07-23       Impact factor: 2.676

Review 3.  The soluble CTLA-4 receptor and its role in autoimmune diseases: an update.

Authors:  Daniele Saverino; Rita Simone; Marcello Bagnasco; Giampaola Pesce
Journal:  Auto Immun Highlights       Date:  2010-11-04

Review 4.  The prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis.

Authors:  Pingping Hu; Qiqi Liu; Guodong Deng; Jingxin Zhang; Ning Liang; Jian Xie; Jiandong Zhang
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.